Jiangsu Hengrui Medicine Co Ltd

We track 2 ClinicalTrials.gov studies led by Jiangsu Hengrui Medicine Co Ltd. The portfolio skews toward Phase 2 (2 trials).

2 clinical trials sponsored by Jiangsu Hengrui Medicine Co Ltd.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials by Jiangsu Hengrui Medicine Co Ltd

A Randomized, Open-Label, Multicenter Phase II Clinical Study of Different Doses of Trastuzumab Rezetecan for Injection or Trastuzumab Deruxtecan for Injection in the Treatment of Unresectable Locally Recurrent/Metastatic Breast Cancer With HR-Positive and HER2-Low Expression

NCT07497386 · NOT YET RECRUITING · Phase 2

An Open Label, Multicenter Phase II Clinical Study on the Safety, Tolerability, and Efficacy of FH-006 Injection Combined With Other Anti-tumor Therapies in Lung Cancer Subjects

NCT07241767 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Jiangsu Hengrui Medicine Co Ltd sponsor?

Jiangsu Hengrui Medicine Co Ltd currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Jiangsu Hengrui Medicine Co Ltd research?

Jiangsu Hengrui Medicine Co Ltd conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Jiangsu Hengrui Medicine Co Ltd recruiting for clinical trials?

Yes, Jiangsu Hengrui Medicine Co Ltd currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More